- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01313026
Treatment of "Low Anterior Resection Syndrome" by Percutaneous Nerve Evaluation and Transanal Irrigation
Treatment of "Low Anterior Resection Syndrome" by Percutaneous Nerve Evaluation and Transanal Irrigation. A Randomized Cross Over Study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients will undergo anal physiological assessment and will then be randomized to either treatment arm. The first 12 weeks they will be optimized in the conservative treatment of their bowel function before beginning active treatment with TAI or PNE. After 8 and 4 weeks respectively, the treatment will stop and they will have a period of 4 weeks back on optimized conservative treatment before beginning active treatment in the other active arm.
Detailed records of bowel, micturition and sexual function and QoL will be obtained at regular intervals during the entire trial fase.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Colorectal Surgical Department P, Aarhus University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Low anterior resection for rectal cancer between May 2001 and May 2011
Exclusion Criteria:
- Non-radical resection
- metastatic disease
- Chemotherapy
- Radiotherapy
- Previously treated for another cancer
- Dementia or other mental retardation/severe mental disease
- Inability to read and understand the Danish language
- Recurrent disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: PNE first
patients randomised to start with PNE stimulation over 4 weeks.
Then the stimulator will be removed and after a wash out period of 4 weeks they will be trained in transanal irrigation
|
Implantation of a nerve stimulator to stimulate the sacral nerve plexus
Other Names:
|
|
Active Comparator: TAI first
Patients randomised to start with transanal irrigation treatment in 8 weeks, thereafter a wash out period of 4 weeks before being implanted with a neuro stimulator
|
Implantation of a nerve stimulator to stimulate the sacral nerve plexus
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes in LARS score
Time Frame: baseline, 12, 16, 20, 24 and 28 weeks
|
A symptom score ranging from 0 to 42 points calculated on the basis of bowel function
|
baseline, 12, 16, 20, 24 and 28 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sexual function
Time Frame: baseline, 12, 16, 20, 24 and 28 weeks
|
self-reported sexual function measured by validated questionnaires
|
baseline, 12, 16, 20, 24 and 28 weeks
|
|
Bladder function
Time Frame: baseline, 12, 16, 20, 24 and 28 weeks
|
self-reported bladder function by validated questionnaires
|
baseline, 12, 16, 20, 24 and 28 weeks
|
|
Incontinence
Time Frame: baseline, 12, 16, 20, 24 and 28 weeks
|
faecal incontinence measured by wexner score and St. Marks incontinence score
|
baseline, 12, 16, 20, 24 and 28 weeks
|
|
Patient Satisfaction
Time Frame: baseline, 12, 16, 20, 24 and 28 weeks
|
patient satisfaction measured on a VAS
|
baseline, 12, 16, 20, 24 and 28 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Katrine J. Emmertsen, MD, University of Aarhus
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LARS 001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.